February 19, 2025
Label Free Detection Market – Global Forecast to 2028 –

[ad_1]

DUBLIN, Sept. 04, 2023 (GLOBE NEWSWIRE) – “Label Free Detection Market Generation by Product and Service (Equipment, Consumables (Biosensor Chips, Microplates), Software), Technology (Surface Plasmon Resonance), Application (Hit Confirmation, Lead) ), By End User (Pharma, CRO) and Region – Global Forecast to 2028” has been added to the report researchandmarkets.com gift.

The global label-free identification market is estimated to reach USD 863 million by 2028 from USD 570 million in 2023, at a CAGR of 8.7% during the forecast period 2023 to 2028.

The label-free identification market is witnessing significant growth owing to the convergence of factors driving advancements in scientific research. Technological advancement has given rise to the introduction of sophisticated products, which have revolutionized the landscape of research and discovery.

Concurrently, synergy between academic and industrial institutions is leading drug discovery programs, fostering innovation through diverse collaborations. The high sensitivity of label-free technologies further enhances their appeal in the scientific community. However, the journey has not been without challenges, as the market continues to grapple with the factor cost constraint affecting its growth path.

Amid these dynamics, industry-academia partnerships have emerged as key enablers, exemplified by Waters Corporation’s alliance with Princeton University. This consortium exemplifies how academia and industry are synergizing their expertise to solve complex scientific challenges.

Such transformative initiatives pave the way for the growth of the label-free identification market, supported by Danaher Corporation, Sartorius AG, Waters Corporation, PerkinElmer Inc., and AMETEK, Inc. is supported by leading players incl.

The biosensor chips segment accounted for the largest share in the consumables during the forecast period

In 2022, the biosensor chips segment is expected to account for the largest share of consumables in the global label-free detection market. Biosensors are important tools in the fields of biochemistry and biomedical engineering as they provide a platform for the detection of various analytes.

Currently, label-free biosensors are widely used in proteomics and biomolecular interaction studies, as the detection of a chemical or biological agent by the transducer does not depend on dyes, enzymes or radiolabels. Traditionally, many small molecules are detected by chromatographic methods, which are generally expensive, bulky and require expertise.

Biosensors provide a cheaper and faster alternative. Some of the advantages of biosensors compared to classical methods for small-molecule detection include real-time monitoring, high specificity, fast response time, low consumption of organic solvents and sample manipulation, portability, compactness, and easy operation. Are.

Europe is the second largest market for label-free identification market after North America

The European label-free identification market has witnessed significant growth in recent years, driven by various factors driving its expansion. Europe is at the forefront of developing and adopting emerging technologies in the label-free identification market. This includes advances in label-free identification technologies.

The adoption of these innovative technologies accelerates the progress of viral vector and plasmid DNA manufacturing research and expands its applications. Additionally, Europe offers extensive training and education programs in label-free identification technologies.

Universities, research institutes and organizations provide funding and conferences to enhance the knowledge and skills of scientists and researchers. Funding availability promotes the adoption and use of label-free identification technologies in Europe.

Main characteristics:

report attribute Description
number of pages 251
forecast period 2023 – 2028
Estimated market value in 2023 (USD). $570 million
Estimated Market Value (USD) by 2028. $863 million
compound annual growth rate 8.7%
covered area global

premium insight

  • Increasing number of drug discovery programs to drive the market
  • Devices to Dominate North American Label-Free Detection Market in 2022
  • The pharmaceutical and biotechnology company segment to hold the largest share in the APAC market in 2022
  • Pharmaceutical and biotechnology companies to have the largest market share in 2022
  • Asia-Pacific Countries to Register Highest Growth Rate in Label-Free Detection Market from 2023 to 2028

market dynamics

the drivers

  • Technological advances in label-free testing
  • Growing academia-industry partnerships for drug discovery programs
  • High sensitivity of label-free technologies

Compulsion

opportunity

  • Growing Life Science Research in Emerging Economies

the challenges

  • Sample complexity and interference

trends

  • Growing Pharmaceutical Outsourcing
  • Growing Applications of Label-free Electrochemical Sensing Platforms

Company Profile

key players

  • Danaher
  • Sartorius AG
  • Jal Nigam
  • Perkinelmer, Inc.
  • Ametech, Inc.
  • Horiba, Ltd.
  • Spectris
  • Mettler Toledo International, Inc.
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Hitachi Hi-Tech Corporation
  • Attana now
  • brooker

other players

  • Nanotemper Technologies GmbH
  • affinit equipment
  • biosensing equipment
  • Unchained Labs
  • Bionavis Limited
  • Cartera, Inc.
  • nicoya
  • Bioptics Analytical LLC
  • Plexra Bioscience
  • Zantek Bioanalytics GmbH
  • Lino Biotec AG (Miltenyi Biotec)
  • Cape Technologies

For more information about this report go here

About ResearchAndMarkets.com
ResearchandMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, major industries, top companies, new products and latest trends.

  • Global Label Free Detection Market

Source: www.globenewswire.com

[ad_2]

Leave a Reply